Azienda Sanitaria Locale Bari

At Azienda Sanitaria Locale Bari, research in cardiovascular diseases focuses on heart failure and atherosclerotic cardiovascular disease, with studies aimed at improving treatment effectiveness, reducing serious heart and vascular events, and refining long-term care.

• Testing new strategies to lower the risk of cardiovascular death, stroke, and other major vascular complications
• Evaluating treatments for heart failure linked to ischemic heart disease
• Studying better use of guideline-based therapy to improve outcomes and quality of life

This work reflects a strong clinical interest in both prevention and optimization of care for patients with complex heart and vascular conditions.

Clinical trials in nervous system diseases at this hospital site are centered on migraine and chronic migraine in children and adolescents, with an emphasis on assessing symptom control, safety, and preventive options.

• Studying new approaches for the acute treatment of migraine in pediatric patients
• Comparing preventive options for adolescents with episodic and chronic migraine
• Assessing whether treatments can reduce migraine burden while remaining well tolerated

These trials support better headache management for younger patients and aim to expand age-appropriate treatment choices.

Oncology research at Azienda Sanitaria Locale Bari includes studies on meningioma and metastatic colorectal cancer, with a focus on improving disease control and evaluating how treatment schedules may affect patient outcomes.

• Exploring treatment options for recurrent grade 2 and grade 3 meningioma
• Testing whether a modified treatment approach can improve results in metastatic colorectal cancer
• Looking at effectiveness, safety, and quality of life in patients with advanced cancer

These studies are designed to refine cancer care by identifying approaches that may better balance benefit and tolerability.

Research in digestive system diseases is represented by trials in colorectal cancer, especially advanced cases that are difficult to treat and require new ways to support disease control.

• Evaluating treatment effectiveness in unresectable left-sided metastatic colorectal cancer
• Studying whether different treatment patterns can improve outcomes and tolerability
• Exploring biological markers linked to response and resistance to therapy

This area combines treatment-focused research with efforts to better understand why some patients respond differently to therapy.

The site also contributes to research on diagnostic and therapeutic techniques, with trials that help evaluate how treatments perform in real-world clinical settings and how outcomes can be measured more effectively.

• Assessing safety, tolerability, and effectiveness across different patient groups
• Supporting the development of more practical treatment strategies for chronic disease care
• Improving understanding of treatment response through clinical and biomarker-based evaluation

These studies complement the disease-specific programs by strengthening the evidence base for everyday clinical decision-making.